Multiplex Assay Kit for Nitric Oxide Synthase 1, Neuronal (NOS1) ,etc. by CBA (Cytometric Bead Array)

NOS; nNOS; IHPS1; NC-NOS; N-NOS; bNOS; Neuronal NOS; Constitutive NOS; NOS type I; Nitric Ocide Synthase; Peptidyl-cysteine S-nitrosylase NOS1

Specificity

This assay has high sensitivity and excellent specificity for detection of Nitric Oxide Synthase 1, Neuronal (NOS1) ,etc. by CBA (Cytometric Bead Array).
No significant cross-reactivity or interference between Nitric Oxide Synthase 1, Neuronal (NOS1) ,etc. by CBA (Cytometric Bead Array) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Nitric Oxide Synthase 1, Neuronal (NOS1) ,etc. by CBA (Cytometric Bead Array) and the recovery rates were calculated by comparing the measured value to the expected amount of Nitric Oxide Synthase 1, Neuronal (NOS1) ,etc. by CBA (Cytometric Bead Array) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 83-98 87
EDTA plasma(n=5) 78-95 91
heparin plasma(n=5) 89-101 95

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Nitric Oxide Synthase 1, Neuronal (NOS1) ,etc. by CBA (Cytometric Bead Array) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Nitric Oxide Synthase 1, Neuronal (NOS1) ,etc. by CBA (Cytometric Bead Array) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Nitric Oxide Synthase 1, Neuronal (NOS1) ,etc. by CBA (Cytometric Bead Array) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 95-102% 79-105% 82-99% 85-99%
EDTA plasma(n=5) 91-104% 95-104% 81-102% 80-104%
heparin plasma(n=5) 83-96% 86-93% 90-104% 97-105%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity

Assay procedure summary

1. Add 200μL analysis buffer solution to each well of the plate for pre-wetting;
2. Preparation of standards, reagents and samples before the experiment;
3. Add 100μL standard or sample to each well, add 10μL magnetic beads, and incubate 120 minutes protect from light at 25°C on shaker;
4. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60 minutes protect from light at 25°C on shaker;
5. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent B, and incubate 30 minutes protect from light at 25°C on shaker;
6. Wash plate once on magnetic frame;
7. Add 100μL sheath fluid, swirl for 10 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
PLoS One A Novel Mechanism of Formaldehyde Neurotoxicity: Inhibition of Hydrogen Sulfide Generation by Promoting Overproduction of Nitric Oxide PubMed: 23359814
J Endocrinol Invest.? The interplay among iron metabolism, endothelium and inflammatory cascade in dysmetabolic disorders Pubmed:25245337
Достижения фундаментальной, клинической медицины и фармации: материалы 72-й науч. сес. сотр. ун-та, 25-26 янв Состояние эндотелиально-сосудистого фактора у беременных с артериальной гипертензией handle:123
Clinical Oral Investigations Clinical antibacterial effectiveness and biocompatibility of gaseous ozone after incomplete caries removal Pubmed:29858659
Journal of Young Pharmacists Antioxydant and Endotheliotropic Properties 4-Hydroxy-3, 5-Di-Tret-Butyl Cinnamic Acid under Conditions of Experimental Brain Ischemia :
The Eurasian Journal of Medicine Tadalafil Preserves Penile Nitric Oxide Synthase from Detrimental Effect of Paroxetine in Rats Doi: 10.5152/eurasianjmed.2018.18160
Oxid Med Cell Longev The Role of Reactive Oxygen Species and Nitric Oxide in the Inhibition of Trichophyton rubrum Growth by HaCaT Cells Pubmed: 32104540
Archives of Oral Biology Mandibular lateral deviation induces alteration in vascular endothelial growth factor expression and oxidative stress/nitric oxide generation in rat condyle, synovial … Pubmed: 31734543
Dovepress Protective Effects of Rocuronium Bromide on Ischemia-Reperfusion Injury in Skeletal Muscle Induced by Tourniquet in Patients Undergoing Elective Unilateral Total … Pubmed: 32884241
Clinical Oral Investigations Evaluation of salivary and serum methylated arginine metabolites and nitric oxide synthase in advanced periodontitis patients Pubmed:35426000
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPA815Hu01 Recombinant Nitric Oxide Synthase 1, Neuronal (NOS1) Positive Control; Immunogen; SDS-PAGE; WB.
PAA815Hu01 Polyclonal Antibody to Nitric Oxide Synthase 1, Neuronal (NOS1) WB
LAA815Hu71 Biotin-Linked Polyclonal Antibody to Nitric Oxide Synthase 1, Neuronal (NOS1) WB; IHC; ICC.
MAA815Hu22 Monoclonal Antibody to Nitric Oxide Synthase 1, Neuronal (NOS1) WB
MAA815Hu21 Monoclonal Antibody to Nitric Oxide Synthase 1, Neuronal (NOS1) WB
SEA815Hu ELISA Kit for Nitric Oxide Synthase 1, Neuronal (NOS1) Enzyme-linked immunosorbent assay for Antigen Detection.
SCA815Hu CLIA Kit for Nitric Oxide Synthase 1, Neuronal (NOS1) Chemiluminescent immunoassay for Antigen Detection.
LMA815Hu Multiplex Assay Kit for Nitric Oxide Synthase 1, Neuronal (NOS1) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
CMA815Hu Multiplex Assay Kit for Nitric Oxide Synthase 1, Neuronal (NOS1) ,etc. by CBA (Cytometric Bead Array) FLIA Kit for Antigen Detection.